Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-02-22 @ 4:53 PM
Study NCT ID:
NCT04248569
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2020-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2029-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-28
First Submit QC Date:
None
Study First Post Date:
2020-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-01
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED